REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenture Life Regulatory News (VLG)

Share Price Information for Venture Life (VLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.75
Bid: 40.00
Ask: 41.50
Change: 0.25 (0.62%)
Spread: 1.50 (3.75%)
Open: 40.20
High: 40.75
Low: 40.20
Prev. Close: 40.50
VLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

6 Jan 2020 15:38

RNS Number : 8950Y
Venture Life Group PLC
06 January 2020
 

6 January 2020

 

Venture Life Group plc

("Venture Life" or the "Company")

Grant of Options

Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the self-care market, announces that it has granted further share options ("Options") over ordinary shares of 0.3 pence each in the capital of the Company ("Ordinary Shares").

On 6 January 2020 (the "Date of Grant"), Venture Life granted Options over a total of 4,000,000 Ordinary Shares to its four Executive Directors at a strike price of 33.7 pence per share, being the average of the closing market price on the five business days starting 19 December 2019. Vesting of the Options is subject to continued employment. The Options will vest in equal tranches on the following dates: 31 March 2020, 31 March 2021 and 31 March 2022.

Director

Position

Number of Options in this grant

Jerry Randall

Chief Executive Officer

 1,000,000

Gianluca Braguti

Chief Manufacturing Officer

 1,000,000

Sharon Collins

Chief Commercial Officer

 1,000,000

Andrew Waters

Chief Financial Officer

 1,000,000

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail. 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.)

Names

1. Jerry Randall

2. Gianluca Braguti

3. Sharon Collins

4. Andrew Waters

2.

Reason for the notification

a.)

Position/status

1. Chief Executive Officer

2. Chief Manufacturing Officer

3. Chief Commercial Officer

4. Chief Financial Officer

b.)

Initial notification /Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.)

Name

Venture Life Group PLC

b.)

LEI

213800S8CZUPLAB2KC70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.)

Description of the financial instrument, type of instrument

Options over Ordinary Shares of 0.3 pence each in Venture Life Group plc

b.)

Identification code

GB00BFPM8908

c.)

Nature of the transaction

Grant of Options over Ordinary Shares

d.)

Price and volumes

 

Price

Volume

1. 33.7 pence

2. 33.7 pence

3. 33.7 pence

4. 33.7 pence

1. 1,000,000

2. 1,000,000

3. 1,000,000

4. 1,000,000

 

 

e.)

Aggregated information

- Aggregated volume

- Price

 

n/a

f.)

Date of the transaction

6 January 2020

g.)

Place of the transaction

Outside a trading venue

 

For further information please contact: 

Venture Life Group PLC

+44 (0) 1344 578 004

Jerry Randall, Chief Executive Officer

Andrew Waters, Chief Financial Officer

 

Cenkos (Nominated Adviser and Joint Broker)

+44 (0) 207 397 8900

Mark Connelly / Stephen Keys / Cameron MacRitchie (Corporate Finance) / Russell Kerr / Michael Johnson (Sales)

Alma PR

venturelife@almapr.com or +44 (0) 203 405 0208

Helena Bogle/Hilary Buchanan/Jessica Joynson

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFVELRIRIII
Date   Source Headline
24th Nov 20207:00 amRNSPDMR Dealings and Issue of Equity
23rd Nov 20208:52 amRNSHolding(s) in Company
20th Nov 20201:00 pmRNSPlacing, Open Offer and Notice of General Meeting
16th Nov 20209:05 amRNSSecond Price Monitoring Extn
16th Nov 20209:00 amRNSPrice Monitoring Extension
16th Nov 20207:00 amRNSResults of in-vitro clinical trial published
9th Nov 20204:40 pmRNSSecond Price Monitoring Extn
9th Nov 20204:36 pmRNSPrice Monitoring Extension
3rd Nov 20209:33 amRNS1000 Companies to Inspire Britain 2020 Report
19th Oct 202012:24 pmRNSHolding(s) in Company
15th Oct 20202:57 pmRNSExercise of Share Options & Voting Rights
9th Oct 20201:39 pmRNSHolding(s) in Company
5th Oct 20201:21 pmRNSHolding(s) in Company
24th Sep 20207:00 amRNSHalf-year Report
25th Aug 202011:59 amRNSHolding(s) in Company
24th Aug 20207:00 amRNSKey oral care brand - clinical trial on COVID-19
20th Jul 20209:05 amRNSSecond Price Monitoring Extn
20th Jul 20209:00 amRNSPrice Monitoring Extension
20th Jul 20207:00 amRNSHalf Year Trading Update
13th Jul 20207:00 amRNSAppointment of Joint Broker
22nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20204:36 pmRNSPrice Monitoring Extension
22nd Jun 202011:05 amRNSSecond Price Monitoring Extn
22nd Jun 202011:00 amRNSPrice Monitoring Extension
11th Jun 20207:00 amRNSHolding(s) in Company
9th Jun 20207:00 amRNSTrading update
3rd Jun 202010:52 amRNSResult of AGM
3rd Jun 20207:00 amRNSAGM Statement
29th May 20203:56 pmRNSHolding(s) in Company
20th May 20207:59 amRNSHolding(s) in Company
19th May 20203:26 pmRNSHolding(s) in Company
19th May 20203:25 pmRNSHolding(s) in Company
19th May 20201:29 pmRNSDirector/PDMR Shareholding
15th May 20207:00 amRNSComment on mouthwash & COVID-19 transmission
29th Apr 20204:15 pmRNSHolding(s) in Company
27th Apr 20209:06 amRNSSecond Price Monitoring Extn
27th Apr 20209:00 amRNSPrice Monitoring Extension
27th Apr 20207:00 amRNSExclusive Long Term Agreement Secured in China
16th Apr 20203:13 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSFinal Results
1st Apr 20203:10 pmRNSNotice of Results
25th Mar 20207:00 amRNSNotice of Results Update and Trading Update
9th Mar 20207:00 amRNSTrading Update and Notice of Results
21st Feb 20207:00 amRNSDirector/PDMR Shareholding
24th Jan 202012:37 pmRNSCompletion of Acquisition
9th Jan 20204:28 pmRNSDirector/PDMR Shareholding
6th Jan 20203:38 pmRNSGrant of Options
19th Dec 20197:00 amRNSAcquisition and Trading Update
18th Nov 20192:02 pmRNSHolding(s) in Company
11th Nov 201911:33 amRNSUltraDEX wins at the Dental Industry Awards 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.